December 3, 2020
Recent findings published in The New England Journal of Medicine, highlight the success of the CANet-funded project, ‘Early Invasive vs. Delayed Intervention for Atrial Fibrillation (EARLY-AF).’ Outcomes indicate that cryoballoon ablation was associated with significant improvement over antiarrhythmic drugs as a first-line intervention in preventing atrial fibrillation (AF) events. EARLY-AF is one of several CANet-funded projects aimed...
Read More

About CANet

CANet is a Pan-Canadian multidisciplinary and multi-sectoral research and development network of investigators, well-positioned industry partners, patients, caregivers, and healthcare providers focused on arrhythmia research, technology development and commercialization, and digital transformation activities.